RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Clinical trials for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM trials appear
Sign up with your email to follow new studies for RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for advanced endometrial cancer: three drug combos face off
Disease control OngoingThis study tested three different drug combinations in 349 people with advanced or recurrent endometrial cancer. The goal was to see which combination worked best to stop the cancer from growing. Participants received either paclitaxel/carboplatin/bevacizumab, paclitaxel/carbopla…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:21 UTC
-
New hope for recurrent ovarian and endometrial cancers: targeted drug shows promise
Disease control OngoingThis study tests a drug called tazemetostat in people whose ovarian or endometrial cancer has returned after previous treatment. The drug works by blocking a protein that helps cancer cells grow. The goal is to see if it can shrink tumors or slow the disease. About 62 participant…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:20 UTC
-
New drug duo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase trial tests a new drug (MLN0128) combined with bevacizumab in people with recurrent glioblastoma (a brain cancer) or other advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side ef…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Gene test trial aims to outsmart advanced cancers
Knowledge-focused OngoingThis study tests whether analyzing the genes in a patient's tumor can help doctors choose a more effective treatment. Over 6,400 adults with advanced or hard-to-treat cancers (solid tumors, lymphoma, or myeloma) had their tumors genetically screened. Those with specific genetic c…
Matched conditions: RECURRENT MALIGNANT UTERINE CORPUS NEOPLASM
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC